Does Methotrexate Increase Skin Cancer Risk? - The …
WEBNov 16, 2015 · NEW YORK (Reuters Health)—Methotrexate appears to increase the risk of recurrent nonmelanoma skin cancer (NMSC) in patients with rheumatoid arthritis (RA), according to a retrospective study.
Use of methotrexate and risk of skin cancer: a nationwide case
WEBFeb 4, 2023 · Methotrexate (MTX) use has been suspected of increasing the risk of skin cancer. The aim of this investigation was to examine the association between the use of MTX and the risk of...
Methotrexate may be Linked to Higher Risk of Skin Cancers
WEBFeb 22, 2023 · A new study published in the British Journal of Cancer found that methotrexate (MTX) could be a risk factor for 3 types of skin cancer: basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC), and cutaneous malignant melanoma (CMM). 1 MTX was only found to present an increased risk for basal cell carcinoma for patients who take the ...
Association Between Low-Dose Methotrexate Exposure and …
WEBDespite decades of clinical use, some studies suggest that low-dose methotrexate may be associated with an increased risk of skin cancer. 9 Prospective studies, including clinical trials, have shown a possible association with increased risk of melanoma, although these studies are limited by a very low number of melanoma events and short ...
Risk of melanoma and nonmelanoma skin cancer with …
WEBBased on available evidence, there may be an indication for routine skin cancer surveillance in patients receiving prolonged courses (greater than 1 year) or high cumulative doses of methotrexate, particularly those with prior …
Use of methotrexate and risk of skin cancer: a nationwide case …
WEBBackground: Methotrexate (MTX) use has been suspected of increasing the risk of skin cancer. The aim of this investigation was to examine the association between the use of MTX and the risk of basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC) and cutaneous malignant melanoma (CMM).
Methotrexate May Be Associated With an Increased Risk for Some Skin Cancers
WEBFeb 8, 2023 · Methotrexate may be linked to an elevated risk of three types of skin cancer, according to a new study published by Polesie et al in the British Journal of Cancer. Additionally, among patients taking the drug to treat moderate to severe psoriasis, an increased risk was observed only for basal cell carcinoma. Background.
Study finds use of methotrexate is associated with an increased …
WEBFeb 7, 2023 · The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows.
Psoriasis Patients Treated With Methotrexate Have an Increased …
WEBApr 5, 2023 · Based on these findings, psoriasis patients treated with methotrexate are at a significantly increased (2.8 times higher) risk of developing nonmelanoma skin cancer. Risk counseling can improve healthcare outcomes in patients with psoriasis.
WEBBACKGROUND: Methotrexate (MTX) use has been suspected of increasing the risk of skin cancer. The aim of this investigation was to examine the association between the use of MTX...